Carl Domino’s Sarepta Therapeutics SRPT Stock Holding History

Carl Domino’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$590K	Hold	13,000	–	–	0.72%	51
2017 Q2	$438K	Hold	13,000	–	–	0.51%	57
2017 Q1	$385K	Hold	13,000	–	–	0.42%	65
2016 Q4	$357K	Hold	13,000	–	–	0.38%	65
2016 Q3	$793K	Hold	13,000	–	–	0.75%	55
2016 Q2	$248K	Hold	13,000	–	–	0.23%	97
2016 Q1	$254K	Sell	13,000 -1,425	-10%	-$24.9K	0.23%	93
2015 Q4	$557K	Hold	14,425	–	–	0.44%	64
2015 Q3	$463K	Hold	14,425	–	–	0.37%	68
2015 Q2	$439K	Hold	14,425	–	–	0.3%	73
2015 Q1	$192K	Sell	14,425 -1,000	-6%	-$13.3K	0.14%	145
2014 Q4	$223K	Buy	15,425 +5,900	+62%	+$99.9K	0.12%	145
2014 Q3	$201K	Buy	+9,525	New	+$215K	0.11%	154
2014 Q2	–	Sell	-8,625	Closed	-$207K	–	174
2014 Q1	$207K	Sell	8,625 -1,900	-18%	-$48.4K	0.11%	156
2013 Q4	$214K	Buy	10,525 +3,985	+61%	+$118K	0.12%	148
2013 Q3	$309K	Buy	6,540 +540	+9%	+$20.8K	0.18%	103
2013 Q2	$228K	Buy	+6,000	New	+$215K	0.13%	123

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Carl Domino's SRPT Position: Q3 2017 in Review

Carl Domino held its Sarepta Therapeutics (SRPT) position steady in Q3 2017 at 13,000 shares worth $590K. The position accounts for 0.72% of the portfolio, ranked #51.

Carl Domino first reported a position in SRPT in Q2 2013 and has held it in 17 quarters since. The position peaked at $793K in Q3 2016. 233 funds tracked by Wall St. Rank hold SRPT as of Q3 2017.

Carl Domino held 13,000 shares of Sarepta Therapeutics worth $590K as of Q3 2017.
Carl Domino left its Sarepta Therapeutics share count unchanged in Q3 2017.
Sarepta Therapeutics made up 0.72% of Carl Domino's portfolio in Q3 2017, its #51 holding.
Carl Domino first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 17 quarters since.
Carl Domino's Sarepta Therapeutics position peaked at $793K in Q3 2016.
233 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2017.

Based on Carl Domino's 13F filing for Q3 2017, filed 7 Nov 2017.